Form D · Hedge Fund

EP Life Sciences Ltd.

New York, NY · CIK 0001744905

Offering snapshot reported Mar 16, 2026 · SEC filing

Reported sold
$52.8M
Indefinite offering
Investors reported
22
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Jul 1, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$26.4M$52.8MJun 28, 2018Mar 28, 2022: $48,455,099.00Mar 27, 2023: $46,939,908.00Mar 26, 2024: $46,111,375.00Mar 21, 2025: $46,309,988.00Mar 16, 2026: $52,817,488.00Mar 16, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$46,309,988 → $52,817,488
  • Reported investors20 → 22

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 16, 2026Amendment$52,817,488$6,507,500vs Mar 21, 202522SEC filing
Mar 21, 2025Amendment$46,309,988$198,613vs Mar 26, 202420SEC filing
Mar 26, 2024Amendment$46,111,375-$828,533vs Mar 27, 202326SEC filing
Mar 27, 2023Amendment$46,939,908-$1,515,191vs Mar 28, 202226SEC filing
Mar 28, 2022Amendment$48,455,099No comparison19SEC filing
Jun 8, 2021AmendmentYet to sellNo comparison19SEC filing
Jun 8, 2020AmendmentYet to sellNo comparison19SEC filing
Jun 17, 2019AmendmentYet to sellNo comparison16SEC filing
Jun 28, 2018InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-315691

Source: Form D, filed Mar 16, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

EP LIFE SCIENCES LTD.

Investment adviser: EHRENKRANZ PARTNERS L.P.

Gross asset value
$93.3M
Beneficial owners
22
ADV minimum commitment
$500K

Reported in Form ADV on Jun 8, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SEI GLOBAL SERVICES INC OAKS, Pennsylvania, United States Investor statements: No (provided to no investors) Related to adviser: No
Auditor ERNST & YOUNG LLP NEW YORK, New York, United States
Custodian BMO HARRIS BANK N.A. CHICAGO, Illinois, United States Related to adviser: No
Custodian PERSHING ADVISOR SOLUTIONS LLC JERSEY CITY, New Jersey, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

ERNST & YOUNG LLP
PCAOB 42

PERSHING ADVISOR SOLUTIONS LLC
SEC 8-47425

Filing source

Form ADV 2103114 · Jun 8, 2026 · Schedule D 7.B.(1), fund 805-8737747127

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steven W Davdson Director
Kurt Dudas Director
Michael Fierro Director
Kabir S Kapoor Director
Gregory Link Director
Marty Piccinich Director
Patrick Jc Shaw Director
Ralph Woodford Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
375 Park Avenue
New York, NY, 10152